TLC BioSciences Corp. (TPEX:7924)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
195.50
-15.00 (-7.13%)
At close: Jul 29, 2026
Market Cap28.85B
Revenue (ttm)89.44M -52.7%
Net Income-653.25M
EPS-7.84
Shares Out 133.56M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume158,176
Open207.50
Previous Close210.50
Day's Range185.50 - 207.50
52-Week Range163.00 - 300.00
Betan/a
Analystsn/a
Price Targetn/a
Earnings Daten/a

About TLC BioSciences

TLC BioSciences Corp. operates as a clinical-stage biotechnology company that develops and sells lipid-engineered medicines in Taiwan, the United States of America, Europe, and the Cayman Islands. It offers products based on its proprietary LipAD, a drug delivery platforms, including BioSeizer for sustained release; NanoX for targeted delivery; and Genosphere for regenerative medicine. The company's pipeline includes candidates for orthopedics and pain management, metabolic and immune disorders, and infectious diseases. The company was founded ... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1997
Country Cayman Islands
Stock Exchange Taipei Exchange
Ticker Symbol 7924
Full Company Profile

Financial Performance

Financial Statements